Literature DB >> 24425877

CD2-associated protein (CD2AP) enhances casitas B lineage lymphoma-3/c (Cbl-3/c)-mediated Ret isoform-specific ubiquitination and degradation via its amino-terminal Src homology 3 domains.

Gina N Calco1, Olivia R Stephens, Laura M Donahue, Cynthia C Tsui, Brian A Pierchala.   

Abstract

Ret is the receptor tyrosine kinase for the glial cell line-derived neurotrophic factor (GDNF) family of neuronal growth factors. Upon activation by GDNF, Ret is rapidly polyubiquitinated and degraded. This degradation process is isoform-selective, with the longer Ret51 isoform exhibiting different degradation kinetics than the shorter isoform, Ret9. In sympathetic neurons, Ret degradation is induced, at least in part, by a complex consisting of the adaptor protein CD2AP and the E3-ligase Cbl-3/c. Knockdown of Cbl-3/c using siRNA reduced the GDNF-induced ubiquitination and degradation of Ret51 in neurons and podocytes, suggesting that Cbl-3/c was a predominant E3 ligase for Ret. Coexpression of CD2AP with Cbl-3/c augmented the ubiquitination of Ret51 as compared with the expression of Cbl-3/c alone. Ret51 ubiquitination by the CD2AP·Cbl-3/c complex required a functional ring finger and TKB domain in Cbl-3/c. The SH3 domains of CD2AP were sufficient to drive the Cbl-3/c-dependent ubiquitination of Ret51, whereas the carboxyl-terminal coiled-coil domain of CD2AP was dispensable. Interestingly, activated Ret induced the degradation of CD2AP, but not Cbl-3/c, suggesting a potential inhibitory feedback mechanism. There were only two major ubiquitination sites in Ret51, Lys(1060) and Lys(1107), and the combined mutation of these lysines almost completely eliminated both the ubiquitination and degradation of Ret51. Ret9 was not ubiquitinated by the CD2AP·Cbl-3/c complex, suggesting that Ret9 was down-regulated by a fundamentally different mechanism. Taken together, these results suggest that only the SH3 domains of CD2AP were necessary to enhance the E3 ligase activity of Cbl-3/c toward Ret51.

Entities:  

Keywords:  Neurodevelopment; Neurotrophic Factor; Protein Degradation; Receptor Tyrosine Kinase; Ubiquitination

Mesh:

Substances:

Year:  2014        PMID: 24425877      PMCID: PMC3953248          DOI: 10.1074/jbc.M113.537878

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase.

Authors:  C A Joazeiro; S S Wing; H Huang; J D Leverson; T Hunter; Y C Liu
Journal:  Science       Date:  1999-10-08       Impact factor: 47.728

Review 2.  Ubiquitin and the control of protein fate in the secretory and endocytic pathways.

Authors:  J S Bonifacino; A M Weissman
Journal:  Annu Rev Cell Dev Biol       Date:  1998       Impact factor: 13.827

3.  Characterization of an NGF-P-TrkA retrograde-signaling complex and age-dependent regulation of TrkA phosphorylation in sympathetic neurons.

Authors:  B A Tsui-Pierchala; D D Ginty
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

4.  cbl-3: a new mammalian cbl family protein.

Authors:  M M Keane; S A Ettenberg; M M Nau; P Banerjee; M Cuello; J Penninger; S Lipkowitz
Journal:  Oncogene       Date:  1999-06-03       Impact factor: 9.867

5.  Distinct turnover of alternatively spliced isoforms of the RET kinase receptor mediated by differential recruitment of the Cbl ubiquitin ligase.

Authors:  Rizaldy P Scott; Susanna Eketjäll; Helena Aineskog; Carlos F Ibáñez
Journal:  J Biol Chem       Date:  2005-01-27       Impact factor: 5.157

6.  Glial cell line-derived neurotrophic factor and its receptor ret is a novel ligand-receptor complex critical for survival response during podocyte injury.

Authors:  Cynthia C Tsui; Stuart J Shankland; Brian A Pierchala
Journal:  J Am Soc Nephrol       Date:  2006-05-03       Impact factor: 10.121

Review 7.  The Cbl family proteins: ring leaders in regulation of cell signaling.

Authors:  Gayathri Swaminathan; Alexander Y Tsygankov
Journal:  J Cell Physiol       Date:  2006-10       Impact factor: 6.384

8.  The c-Cbl/CD2AP complex regulates VEGF-induced endocytosis and degradation of Flt-1 (VEGFR-1).

Authors:  Satsuki Kobayashi; Asako Sawano; Yoshihisa Nojima; Masabumi Shibuya; Yoshiro Maru
Journal:  FASEB J       Date:  2004-03-04       Impact factor: 5.191

9.  Tyrosine 981, a novel ret autophosphorylation site, binds c-Src to mediate neuronal survival.

Authors:  Mario Encinas; Robert J Crowder; Jeffrey Milbrandt; Eugene M Johnson
Journal:  J Biol Chem       Date:  2004-02-06       Impact factor: 5.157

10.  Glial cell line-derived neurotrophic factor-dependent recruitment of Ret into lipid rafts enhances signaling by partitioning Ret from proteasome-dependent degradation.

Authors:  Brian A Pierchala; Jeffrey Milbrandt; Eugene M Johnson
Journal:  J Neurosci       Date:  2006-03-08       Impact factor: 6.167

View more
  7 in total

1.  Differential Recognition Preferences of the Three Src Homology 3 (SH3) Domains from the Adaptor CD2-associated Protein (CD2AP) and Direct Association with Ras and Rab Interactor 3 (RIN3).

Authors:  Evgenia Rouka; Philip C Simister; Melanie Janning; Joerg Kumbrink; Tassos Konstantinou; João R C Muniz; Dhira Joshi; Nicola O'Reilly; Rudolf Volkmer; Brigitte Ritter; Stefan Knapp; Frank von Delft; Kathrin H Kirsch; Stephan M Feller
Journal:  J Biol Chem       Date:  2015-08-20       Impact factor: 5.157

2.  Complementary genetic screens identify the E3 ubiquitin ligase CBLC, as a modifier of PARP inhibitor sensitivity.

Authors:  Jessica Frankum; Pavel Moudry; Rachel Brough; Zdenek Hodny; Alan Ashworth; Jiri Bartek; Christopher J Lord
Journal:  Oncotarget       Date:  2015-05-10

3.  Brain ischemia downregulates the neuroprotective GDNF-Ret signaling by a calpain-dependent mechanism in cultured hippocampal neurons.

Authors:  M Curcio; I L Salazar; A R Inácio; E P Duarte; L M T Canzoniero; C B Duarte
Journal:  Cell Death Dis       Date:  2015-02-12       Impact factor: 8.469

4.  ATF4 destabilizes RET through nonclassical GRP78 inhibition to enhance chemosensitivity to bortezomib in human osteosarcoma.

Authors:  Jie Luo; Yuanzheng Xia; Yong Yin; Jun Luo; Mingming Liu; Hao Zhang; Chao Zhang; Yucheng Zhao; Lei Yang; Lingyi Kong
Journal:  Theranostics       Date:  2019-08-14       Impact factor: 11.556

5.  Loss of function Cbl-c mutations in solid tumors.

Authors:  Silvano Rakeem Daniels; Mariya Liyasova; Stephen C Kales; Marion M Nau; Philip E Ryan; Jeffrey E Green; Stanley Lipkowitz
Journal:  PLoS One       Date:  2019-07-01       Impact factor: 3.240

6.  cindr, the Drosophila Homolog of the CD2AP Alzheimer's Disease Risk Gene, Is Required for Synaptic Transmission and Proteostasis.

Authors:  Shamsideen A Ojelade; Tom V Lee; Nikolaos Giagtzoglou; Lei Yu; Berrak Ugur; Yarong Li; Lita Duraine; Zhongyuan Zuo; Vlad Petyuk; Philip L De Jager; David A Bennett; Benjamin R Arenkiel; Hugo J Bellen; Joshua M Shulman
Journal:  Cell Rep       Date:  2019-08-13       Impact factor: 9.423

7.  Non-canonical Ret signaling augments p75-mediated cell death in developing sympathetic neurons.

Authors:  Christopher R Donnelly; Nicole A Gabreski; Esther B Suh; Monzurul Chowdhury; Brian A Pierchala
Journal:  J Cell Biol       Date:  2018-07-17       Impact factor: 10.539

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.